MOLBIO Share Price | Molbio Diagnostics Ltd Stock Analysis & Recommendation

Q: Why is Molbio Diagnostics Ltd falling/rising?

As of 30-Aug, the stock price of Molbio Diagnostics Ltd is falling, currently at 1,097.40, which reflects a decrease of 48.0 points or 4.19%. This decline is part of a broader trend, as the stock has been underperforming, having lost 11.7% over the last two days. Additionally, it has consistently traded below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a sustained downward momentum.Investor participation has also decreased, with delivery volume dropping by 38.79% compared to the 5-day average, suggesting reduced interest in the stock. Furthermore, the stock's performance today has underperformed its sector by 4.76%, contributing to the overall negative sentiment surrounding it. The intraday low of Rs 1077.75, which represents a 5.91% drop, further illustrates the stock's struggles in the current market environment.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

75.91 k (-21.83%) Volume

Shareholding (Aug 2026)

FII

1.51%

Held by 45 FIIs

DII

16.37%

Held by 15 DIIs

Promoter

41.29%

Why is Molbio Diagnostics Ltd falling/rising?

31-Aug-2026

As of 30-Aug, the stock price of Molbio Diagnostics Ltd is currently 1,097.40, reflecting a decline of 4.19% and an overall loss of 11.7% over the last two days. The stock is underperforming with decreased investor participation and consistently trading below key moving averages.

View full answer

Which are the latest news on Molbio Diagnosti?

31-Aug-2026

No latest news for Molbio Diagnosti found.

Compare Molbio Diagnosti with Similar Stocks

Indegene Metropolis Healt Vijaya Diagnost.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Healthcare Services

Market cap

INR 12,590 Cr (Mid Cap)

P/E

86.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.09

Return on Equity

14.78%

Price to Book

12.77

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

Company does not have enough history

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

Board Meeting Outcome for Outcome Of Board Meeting Held On August 27 2026 As Per Reg 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations).

27-Aug-2026 | Source : BSE

Outcome of Board Meeting held on August 27 2026 as per Reg 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations).

Closure of Trading Window

20-Aug-2026 | Source : BSE

Intimation of Closure Trading Window as per SEBI (Prohibition of Insider Trading) Regulations 2015

Listing of Equity Shares of Molbio Diagnostics Ltd

17-Aug-2026 | Source : BSE

Trading Members of the Exchange are hereby informed that effective from August 17 2026 the Equity Shares of Molbio Diagnostics Ltd (Scrip Code: 544866) are listed and admitted to dealings on the Exchange in the list of B Group Securities. For further details please refer to the notice no 20260814- dated August 14 2026.

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

23.08

Debt to EBITDA (avg)

0.88

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.92

Tax Ratio

25.64%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

17.89%

ROCE (avg)

21.92%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

12.66

EV to EBIT

62.44

EV to EBITDA

38.71

EV to Capital Employed

13.88

EV to Sales

8.61

PEG Ratio

Dividend Yield

ROCE (Latest)

22.23%

ROE (Latest)

14.78%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

Bollinger Bands

KST

Dow Theory

OBV

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Aug 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 13 Schemes (2.25%)

FIIs

Held by 45 FIIs (1.51%)

Promoter with highest holding

Exxora Trading Llp (37.05%)

Highest Public shareholder

Business Excellence Trust Iii - India Business Exc (11.52%)

Individual Investors Holdings

27.64%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Molbio Diagnosti"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Molbio Diagnosti"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Molbio Diagnosti"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Molbio Diagnosti"
  }
]

Company CV

About Molbio Diagnostics Ltd

Molbio Diagnostics Ltd

Mid Cap

Healthcare Services

No Details Available.

Company Coordinates

No Company Details Available